Free Trial
NYSE:ENFN

Enfusion (ENFN) Stock Price, News & Analysis

Enfusion logo
$10.85 +0.05 (+0.45%)
Closing price 04/17/2025
Extended Trading
$10.85 0.00 (0.00%)
As of 04/17/2025 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Enfusion Stock (NYSE:ENFN)

Key Stats

Today's Range
$10.74
$10.87
50-Day Range
$10.85
$10.85
52-Week Range
$7.83
$11.80
Volume
2.46 million shs
Average Volume
703,905 shs
Market Capitalization
$1.40 billion
P/E Ratio
271.29
Dividend Yield
N/A
Price Target
$12.25
Consensus Rating
Hold

Company Overview

Receive ENFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter.

ENFN Stock News Headlines

Clearwater Analytics reinstated with an Overweight at JPMorgan
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Clearwater Analytics Finalizes Acquisition of Enfusion
See More Headlines

ENFN Stock Analysis - Frequently Asked Questions

Enfusion's stock was trading at $10.30 at the beginning of 2025. Since then, ENFN shares have increased by 5.3% and is now trading at $10.8490.

Enfusion, Inc. (NYSE:ENFN) issued its quarterly earnings data on Monday, March, 3rd. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.03 by $0.02. The company earned $52.94 million during the quarter, compared to analysts' expectations of $53.98 million. Enfusion had a net margin of 1.70% and a trailing twelve-month return on equity of 6.67%.

Enfusion (ENFN) raised $300 million in an initial public offering on Thursday, October 21st 2021. The company issued 18,750,000 shares at a price of $15.00-$17.00 per share.

Shares of ENFN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enfusion investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Tesla (TSLA), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

Last Earnings
3/03/2025
Today
7/03/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
Computer Software
Current Symbol
NYSE:ENFN
Fax
N/A
Employees
890
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.25
High Stock Price Target
$13.00
Low Stock Price Target
$11.50
Potential Upside/Downside
+12.9%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
271.29
Forward P/E Ratio
180.82
P/E Growth
1.85
Net Income
$6.03 million
Pretax Margin
3.64%

Debt

Sales & Book Value

Annual Sales
$201.61 million
Cash Flow
$0.14 per share
Price / Cash Flow
78.75
Book Value
$0.61 per share
Price / Book
17.79

Miscellaneous

Free Float
81,720,000
Market Cap
$1.40 billion
Optionable
Optionable
Beta
0.92

Social Links

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NYSE:ENFN) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners